Biotechnology and pharmaceutical businesses of all sizes are under intense pressure to leverage the commercial potential of their intellectual property, as fully and rapidly as possible.
The L&A life sciences team has tremendous experience working with biotechnology and pharmaceutical companies of all sizes and stages—from venture-funded organizations in early discovery stages to multinational corporations with established product portfolios. We also represent venture capital groups, private equity funds, and ultra-high-net-worth individuals and other entities that invest in or evaluate IP in the life sciences. Some team members also have experience as in-house counsel in the pharmaceutical industry. We combine PhD-level knowledge in molecular biology, organic chemistry, and related disciplines with a deep understanding of the commercial and legal realities that drive business success.
We take a strategic approach, integrating IP with each client’s business, scientific, product, regulatory, financing, and competitive circumstances. The result is a tailored solution that reflects client priorities, anticipates future needs, and balances IP protection with budget realities.
Our vast experience in this specialized industry enables L&A to:
We serve public and private companies of all sizes, as well as venture capital partnerships and investors, in a range of commercial life science areas, including: